TELA Bio preliminary Q1 revenue $11.9M, up 45% YoY; cash $30.1M

TELA Bio, Inc.

2023-Q1 EPS reported -$0.63 revenue$11,909,000

Revenue estimated at $11.9M for Q1 2023 vs $8.2M in Q1 2022, a 45% increase.
Cash and equivalents $30.1M at March 31, 2023, down from $42.0M at Dec 31, 2022.
Results are preliminary and subject to change upon completion of quarter-end closing.

item 2.02

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

TELA Bio, Inc. reported the first quarter ended March 31, 2023 results: revenue $11.9 million.

Period: the first quarter ended March 31, 2023
Revenue: $11.9 million
Result: preliminary results

Exact text from the filing

Revenue for the three months ended March 31, 2023 is estimated to be $11.9 million, compared to $8.2 million over the corresponding period of 2022.

View on SEC.gov

49 earnings releases filed in the last 30 days. Browse all earnings releases →

TELA Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-046698

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.